Get the Stockscreener App
24.65
5.78%
-1.411
Enovis Corp stock is traded at $24.65, with a volume of 604.85K.
It is down -5.78% in the last 24 hours and down -9.30% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$26.06
Open:
$25.47
24h Volume:
604.85K
Relative Volume:
0.52
Market Cap:
$1.42B
Revenue:
$2.28B
Net Income/Loss:
$-1.13B
P/E Ratio:
-1.2411
EPS:
-19.86
Net Cash Flow:
$35.92M
1W Performance:
+1.29%
1M Performance:
-9.30%
6M Performance:
+13.52%
1Y Performance:
-16.91%
1-Day Range:
$24.50
$25.75
1-Week Range:
$23.62
$26.44
52-Week Range:
$19.14
$34.28
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
24.66 | 1.50B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
109.68 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.39 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.62 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.45 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.73 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Resumed | William Blair | Outperform |
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
ENOV Maintained by Canaccord Genuity -- Price Target Lowered to $45 - GuruFocus
Why Is Enovis (NYSE) a Stock to Track on the NYSE Index? - Kalkine Media
Canaccord Genuity Group Lowers Enovis (NYSE:ENOV) Price Target to $45.00 - marketbeat.com
Rubric Capital discloses 3.9M-share Enovis (ENOV) position in Schedule 13G - Stock Titan
Enovis Corporation (ENOV) Stock Forecasts - Yahoo! Finance Canada
Can Enovis (ENOV) Narrowing Losses Without Strong Sales Growth Sustain Its Long-Term Strategy? - simplywall.st
Enovis Corp (ENOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enovis (ENOV) Reaffirmed Guidance And Improved Margins, Is The Stock Still Undervalued? - simplywall.st
Enovis (NYSE:ENOV) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS - marketbeat.com
Enovis (ENOV) Stock Eyes Margin Gains as Free Cash Flow Improves - webull.com
Should You Investigate Enovis Corporation (NYSE:ENOV) At US$26.61? - 富途牛牛
CCORF Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $50 - Moomoo
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Enovis Q2 Earnings Call Highlights - MarketBeat
Enovis (NYSE:ENOV) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Enovis Corp (ENOV) Stock News Today - TradingKey
ENOV Maintained by Wells Fargo -- Price Target Lowered to $39 - GuruFocus
Sei Investments Co. Purchases 44,474 Shares of Enovis Corporation $ENOV - marketbeat.com
Wells Fargo & Company Lowers Enovis (NYSE:ENOV) Price Target to $39.00 - marketbeat.com
BMO Capital Maintains Enovis Corp(ENOV.US) With Buy Rating, Raises Target Price to $30 - 富途牛牛
Enovis Shares Fall After Fiscal Q2 Results - Moomoo
Earnings call transcript: Enovis tops Q2 2026 EPS view but shares fall 6.7% - Investing.com Nigeria
Enovis Corp (ENOV) (Q2 2026) Earnings Call Highlights: Strong In - GuruFocus
Enovis Corporation 2026 Q2ResultsEarnings Call Presentation (NYSE:ENOV) 2026-08-07 - Seeking Alpha
Enovis Q2 2026 slides: margins expand but shares fall on outlook - Investing.com
Enovis Q2 2026 slides show margin gains despite stock decline - Investing.com
Enovis earnings beat by $0.05, revenue topped estimates - Investing.com
Enovis Q2 2026 presentation shows margin gains, stock falls 9% - Investing.com
Enovis Corporation Stock 12‑Month Price Target Cut to $41.25, Implies 37% Upside - TradingView
Enovis Backs 2026 Guidance >ENOV - moomoo.com
Enovis shares drop after reporting ‘softer than expected’ Q2 earnings - MassDevice
ENOV Maintained by BTIG -- Price Target Raised to $40.00 - GuruFocus
ENOV Looks 40.0% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Why Enovis (ENOV) Shares Are Sliding Today - StockStory
Enovis (NYSE:ENOV) Given New $40.00 Price Target at BTIG Research - MarketBeat
What Is Fueling Enovis (NYSE:ENOV) After Q2 Earnings? - Kalkine Media
Enovis (NYSE:ENOV) Shares Down 9.3%Should You Sell? - MarketBeat
Form 8K Enovis Corp For: 6 August By Investing.com - Investing.com South Africa
Is Enovis Corp (ENOV) a Value Trap After a Q2 Loss? EPS Misses E - GuruFocus
Enovis Corporation reports results for the quarter ended June 30Earnings Summary - TradingView
Enovis (NYSE:ENOV) Posts Q2 CY2026 Sales In Line With Estimates - StockStory
Enovis beats second quarter EPS estimate, reaffirms guidance - Investing.com
Enovis beats second quarter EPS estimate, reaffirms guidance By Investing.com - Investing.com Nigeria
Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Enovis Corporation Reaffirms Earnings Guidance for the Year 2026 - marketscreener.com
Enovis CORP 2026: Revenue $582.78M, EPS ($0.02) — 10-Q Summary - TradingView
Enovis: Q2 Earnings Snapshot - marketscreener.com
Enovis Q2 2026 Sales Rise 3 Percent to $583 Million - Quiver Quantitative
Enovis posts Q2 2026 revenue $583M, adjusted EBITDA $104M and reaffirmed full-year guidance - TradingView
Earnings Flash (ENOV) Enovis Corporation Posts Q2 Adjusted EPS $0.90 per Share, vs. FactSet Est of $0.85 - marketscreener.com
Enovis Q2 2026 earnings: Reconstructive growth lifts margins - TradingKey
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):